On Wednesday, Abbott Laboratories (NYSE: ABT) forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics units overshadowed […]
Abbott Issues Downbeat Q1 Profit Outlook, Stock Dips Read More »
A Missouri mother and her lawyers this week will aim to convince a jury that Abbott (NYSE: ABT), Reckitt’s Mead
Abbott and Reckitt Face Trial Over Premature Baby Formula Amid Alarm From Doctors Read More »
Abbott Laboratories (NYSE: ABT) has launched its over-the-counter continuous glucose monitoring system in the U.S., the company said on Thursday,
Abbott (NYSE: ABT) Debuts OTC Glucose Monitoring System in the US, Rivals Dexcom Read More »
Similac baby formula maker Abbott (NYSE: ABT) is expected to face a trial on Monday over claims that its formula
Abbott (NYSE: ABT) Faces Trial Over Claims of Infant Formula-Linked Disease Risks Read More »
Copyright © 2025 abbonews.com
